Compounds > 6-anilino-5,8-quinolinedione

6-anilino-5,8-quinolinedione and bucladesine

6-anilino-5,8-quinolinedione has been researched along with bucladesine in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (50.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Agah, A; Buras, J; Collard, CD; Reenstra, W; Stahl, GL	1
Carretero, OA; D'Ambrosio, MA; Falck, JR; Garvin, JL; Peterson, EL; Ren, Y; Wang, H	1

Other Studies

2 other study(ies) available for 6-anilino-5,8-quinolinedione and bucladesine

Article	Year
Endothelial nuclear factor-kappaB translocation and vascular cell adhesion molecule-1 induction by complement: inhibition with anti-human C5 therapy or cGMP analogues. Arteriosclerosis, thrombosis, and vascular biology, 1999, Volume: 19, Issue:11 Topics: Aminoquinolines; Antibodies, Monoclonal; Blotting, Western; Bucladesine; Cell Hypoxia; Cells, Cultured; Complement Membrane Attack Complex; Cyclic GMP; Dibutyryl Cyclic GMP; Endothelium, Vascular; Enzyme Inhibitors; Enzyme-Linked Immunosorbent Assay; Fluorescent Antibody Technique; Glutathione; Humans; Immunotherapy; Intercellular Adhesion Molecule-1; NF-kappa B; NG-Nitroarginine Methyl Ester; Nitric Oxide Donors; Nitroso Compounds; Oxygen; Penicillamine; S-Nitrosoglutathione; Umbilical Veins; Vasculitis; Vasodilation	1999
Mechanisms of carbon monoxide attenuation of tubuloglomerular feedback. Hypertension (Dallas, Tex. : 1979), 2012, Volume: 59, Issue:6 Topics: Aminoquinolines; Animals; Arterioles; Bucladesine; Carbazoles; Carbon Monoxide; Cyclic AMP; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; Cyclic Nucleotide Phosphodiesterases, Type 2; Enzyme Inhibitors; Feedback, Physiological; Guanylate Cyclase; Imidazoles; In Vitro Techniques; Kidney Glomerulus; Kidney Tubules, Distal; Organometallic Compounds; Rabbits; Triazines	2012

Article

Year

Endothelial nuclear factor-kappaB translocation and vascular cell adhesion molecule-1 induction by complement: inhibition with anti-human C5 therapy or cGMP analogues.

Arteriosclerosis, thrombosis, and vascular biology, 1999, Volume: 19, Issue:11

Topics: Aminoquinolines; Antibodies, Monoclonal; Blotting, Western; Bucladesine; Cell Hypoxia; Cells, Cultured; Complement Membrane Attack Complex; Cyclic GMP; Dibutyryl Cyclic GMP; Endothelium, Vascular; Enzyme Inhibitors; Enzyme-Linked Immunosorbent Assay; Fluorescent Antibody Technique; Glutathione; Humans; Immunotherapy; Intercellular Adhesion Molecule-1; NF-kappa B; NG-Nitroarginine Methyl Ester; Nitric Oxide Donors; Nitroso Compounds; Oxygen; Penicillamine; S-Nitrosoglutathione; Umbilical Veins; Vasculitis; Vasodilation

1999

Mechanisms of carbon monoxide attenuation of tubuloglomerular feedback.

Hypertension (Dallas, Tex. : 1979), 2012, Volume: 59, Issue:6

Topics: Aminoquinolines; Animals; Arterioles; Bucladesine; Carbazoles; Carbon Monoxide; Cyclic AMP; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; Cyclic Nucleotide Phosphodiesterases, Type 2; Enzyme Inhibitors; Feedback, Physiological; Guanylate Cyclase; Imidazoles; In Vitro Techniques; Kidney Glomerulus; Kidney Tubules, Distal; Organometallic Compounds; Rabbits; Triazines

2012